NCT06885073

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Compremium AG · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

Conditions

• Central Venous Pressure

Interventions

Type	Name	Description
DEVICE	CPMX2	CPMX2 - Non-invasive pressure estimation

Timeline

• Start date: 2025-03-10
• Primary completion: 2026-03-31
• Completion: 2026-03-31
• First posted: 2025-03-20
• Last updated: 2025-09-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study